🤖 GLOBAL HEALTH OPTIMIZATION AGENT v3.0

🔬 Current Disease Focus:

Task Progress: 0%

👥 Active Problem Solvers

🌍 Experts collaborating globally

⚡ Current Task Assignment

🧬 Genetic Analysis

🔄 Matching experts to specific tasks

📊 Resource Allocation by Research Phase:

📚 Data Analysis

🧪 Experimental Design

🔬 Clinical Trials

💊 Treatment Development

Trial Search

Current Search Criteria:

Intervention: Ribavirin (SCH 18908)

Found 46 matching trials

Adherence in Patients Receiving PegIntron Pen/Rebetol for Hepatitis C in Conjunction With a Patient Assistance Program (Study P04281)(COMPLETED)

N/A

Patients receiving a patient assistance program during therapy for Hepatiti...

Status

Completed

Location

Multiple Locations

Start Date

2005-03

Trial ID

NCT00704522

Treatments Being Tested

Peginterferon alfa-2b (SCH 54031)Ribavirin (SCH 18908)Patient assistance program

Evaluation of Satisfaction in Patients Receiving PegIntron Pen/Rebetol for Hepatitis C (Study P04067)

N/A

The current gold standard for treatment of chronic hepatitis C (CHC) patien...

Status

Completed

Location

Multiple Locations

Start Date

2004-10

Trial ID

NCT00727259

Treatments Being Tested

Peginterferon alfa-2b (SCH 54031)Ribavirin (SCH 18908)

Patient Compliance During PegIntron and Rebetol Combination Therapy in Chronic Hepatitis C (Study P04690)

N/A

Participants will receive PegIntron injection pen (Peginterferon alfa-2b) a...

Status

Completed

Location

Multiple Locations

Start Date

2006-03

Trial ID

NCT00725205

Treatments Being Tested

PegIntron (Peginterferon alfa-2b)Rebetol (Ribavirin)

Compliance of HCV Genotype 1 Infected Patients Receiving PegIntron/Rebetol and a Patient Assistance Program (Study P04671)

N/A

Enrolled patients will be recruited to two parallel groups during therapy f...

Status

Completed

Location

Multiple Locations

Start Date

2005-10

Trial ID

NCT00728494

Treatments Being Tested

PegIntron (peginterferon alfa-2b; SCH 54031)Rebetol (ribavirin; SCH 18908)Patient Assistance Program

Pegylated Interferon (PEG-IFN) Alfa-2b and Low Dose Ribavirin for the Treatment of Chronic Hepatitis C Patients With Genotype 1 High Viral Load and Low Body Weight (Study P05172)(COMPLETED)

PHASE4

The objective is to evaluate the efficacy and safety of the combination the...

Status

Completed

Location

Multiple Locations

Start Date

2008-01

Trial ID

NCT00686777

Treatments Being Tested

Pegylated Interferon alfa-2b Ribavirin

Effect of Infliximab on the Efficacy of Peg-Intron/Ribavirin in Patients With Hepatitis C (Study P04257AM4)(COMPLETED)

PHASE3

This is a Phase IIIB, randomized, prospective, multicenter, single-country,...

Status

Completed

Location

Multiple Locations

Start Date

2005-07-18

Trial ID

NCT00237484

Treatments Being Tested

Induction dose of (a) infliximab followed by combination of (b) pegylated interferon alfa-2b and (c) ribavirin Combination of (a) pegylated interferon alfa-2b and (b) ribavirin

Effects of 48 Weeks Versus 24 Weeks of Therapy With Peg-Intron/Ribavirin in Patients With Chronic Hepatitis C, Genotype 3 (Study P04143)(TERMINATED)

PHASE4

This is an Australian, open-label, multicenter, randomized, double-blind cl...

Status

Terminated

Location

Multiple Locations

Start Date

2005-02

Trial ID

NCT00255034

Treatments Being Tested

Peginterferon alfa-2b Peginterferon alfa-2b Ribavirin Ribavirin

Post-marketing Surveillance Study of Ex-intravenous Drug Abusers With Chronic Hepatitis C Treated With PegIntron Plus Rebetol (P04408/MK-4031-261)

N/A

Previous intravenous drug abusers with chronic hepatitis C who are under su...

Status

Completed

Location

Multiple Locations

Start Date

2005-10

Trial ID

NCT00726557

Treatments Being Tested

PegIntron (pegylated interferon alfa-2b; SCH 54031)Rebetol (ribavirin; SCH 18908)

Impact of Patient Support by the Medical Staff on Adherence to Therapy With PegIntron Plus Rebetol (Study P04413)

N/A

The objective of this study is to assess the impact of participant care and...

Status

Completed

Location

Multiple Locations

Start Date

2005-05

Trial ID

NCT00704964

Treatments Being Tested

PegIntron Rebetol

Study of PEG-Intron Plus REBETOL in Pediatric Subjects With Chronic Hepatitis C (Study P02538 Part 1)

PHASE3

The primary objective is to assess the safety, efficacy and tolerability of...

Status

Completed

Location

Multiple Locations

Start Date

2005-02

Trial ID

NCT00104052

Treatments Being Tested

peginterferon alfa-2b (PEG2b) (SCH 54031)ribavirin (SCH 18908)

Previous Next